Latest News

A selection of recent news and views from Catapult Ventures follows...

Peter Hamer joins SurgaColl as Chief Executive Officer

Alderley Park, UK – 10th December 2018. SurgaColl, a regenerative medicine company, today announced the appointment of Peter Hamer as Chief Executive Officer. Mr. Hamer succeeds Bill Allan as CEO following Bill’s decision to retire fro...

Maxwellia expand their team with two new appointments

Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator.  Maxwellia, the UK’s only ‘prescription to over the counter (OTC)’ medicines company...

Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics

Shanghai China and Oxford UK, December 11, 2018 –WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing and Oxford Bio...

Med-Tech companies triumph at the Bionow Awards

The outstanding companies and leaders of the North’s life sciences sector – which is worth more than £13bn to the economy- were honoured last night at the 17th annual Bionow Awards. More than 300 people attended the awards d...

Blueberry Therapeutics Announce Positive Results from a Phase I-II Clinical Trial

Alderley Park, UK, 21stNovember 2018– Blueberry Therapeutics Limited (“Blueberry Therapeutics”), a modern drug discovery and development company committed to the development of innovative new therapies for the treatment of common...

From our portfolio

CLYZ Labs

Diagnostics

CLYZ Labs are developing a testing service to select the best drug therapy for personalised cance...

viewview our portfolio

Our Team

Emma Johnson

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
Enderby
Leicester
LE19 4XT

Tel: 0116 238 8200

email